Drug factory · FDA FEI 3005178749
Hubei Haosun Pharmaceutical Co., Ltd.
No.20 Juxian Road, Gedian Economic & Technology Development Area, Ezhou, China
No problems found at FDA's last inspection, Aug 1, 2025.
No Action Indicated: inspectors found no objectionable conditions.
5 drug inspections on record since 2011: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Irinotecan | Makes the active ingredient | Ipsen Biopharmaceuticals, Inc. | 15054-0043 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Aug 1, 2025 | No problems found | Drug Quality Assurance | — |
| Mar 9, 2018 | No problems found | Drug Quality Assurance | — |
| Sep 2, 2016 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Nov 15, 2013 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jul 16, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.